D
52.10
-2.90 (-5.27%)
Previous Close | 55.00 |
Open | 54.04 |
Volume | 2,141,948 |
Avg. Volume (3M) | 2,015,111 |
Market Cap | 9,726,652,416 |
Price / Earnings (TTM) | 59.89 |
Price / Earnings (Forward) | 49.02 |
Price / Sales | 19.14 |
Price / Book | 9.59 |
52 Weeks Range | |
Earnings Date | 6 Feb 2025 - 10 Feb 2025 |
Profit Margin | 33.69% |
Operating Margin (TTM) | 40.68% |
Diluted EPS (TTM) | 0.870 |
Quarterly Revenue Growth (YOY) | 20.40% |
Quarterly Earnings Growth (YOY) | 44.30% |
Total Debt/Equity (MRQ) | 1.40% |
Current Ratio (MRQ) | 7.24 |
Operating Cash Flow (TTM) | 223.59 M |
Levered Free Cash Flow (TTM) | 184.34 M |
Return on Assets (TTM) | 11.83% |
Return on Equity (TTM) | 19.00% |
Market Trend
Short Term | Medium Term | ||
Industry | Health Information Services (US) | Mixed | Bearish |
Health Information Services (Global) | Mixed | Bearish | |
Stock | Doximity, Inc. | Bullish | Bullish |
AIStockmoo Score
-1.3
Analyst Consensus | 1.5 |
Insider Activity | NA |
Price Volatility | -3.5 |
Technical Moving Averages | -2.5 |
Technical Oscillators | -0.5 |
Average | -1.25 |
Doximity Inc is a digital platform for U.S. medical professionals. Its cloud-based platform provides members with tools specifically built for medical professionals, enabling them to collaborate with their colleagues, securely coordinate patient care, conduct virtual patient visits, stay up-to-date with the latest medical news and research, and manage their careers. |
|
Sector | Healthcare |
Industry | Health Information Services |
Investment Style | Small Growth |
% Held by Insiders | 2.74% |
% Held by Institutions | 91.73% |
52 Weeks Range | ||
Price Target Range | ||
High | 75.00 (Barclays, 43.95%) | Buy |
Median | 56.00 (7.49%) | |
Low | 43.00 (Wells Fargo, -17.47%) | Hold |
Average | 56.92 (9.25%) | |
Total | 3 Buy, 9 Hold | |
Avg. Price @ Call | 54.05 |
Firm | Date | Target Price | Call | Price @ Call |
---|---|---|---|---|
Wells Fargo | 13 Jan 2025 | 43.00 (-17.47%) | Hold | 52.10 |
08 Nov 2024 | 41.00 (-21.31%) | Hold | 58.25 | |
Keybanc | 08 Jan 2025 | 65.00 (24.76%) | Buy | 55.00 |
08 Nov 2024 | 70.00 (34.36%) | Buy | 58.25 | |
B of A Securities | 06 Jan 2025 | 57.00 (9.40%) | Hold | 55.57 |
Stephens & Co. | 20 Dec 2024 | 55.00 (5.57%) | Hold | 57.83 |
Mizuho | 04 Dec 2024 | 55.00 (5.57%) | Hold | 54.20 |
JP Morgan | 21 Nov 2024 | 48.00 (-7.87%) | Hold | 48.00 |
Goldman Sachs | 15 Nov 2024 | 58.00 (11.32%) | Hold | 49.40 |
Morgan Stanley | 14 Nov 2024 | 53.00 (1.73%) | Hold | 52.04 |
30 Oct 2024 | 33.00 (-36.66%) | Sell | 41.99 | |
Truist Securities | 14 Nov 2024 | 49.00 (-5.95%) | Hold | 52.04 |
Canaccord Genuity | 13 Nov 2024 | 60.00 (15.16%) | Hold | 52.86 |
Barclays | 11 Nov 2024 | 75.00 (43.95%) | Buy | 61.25 |
15 Oct 2024 | 52.00 (-0.19%) | Buy | 43.86 | |
Raymond James | 08 Nov 2024 | 65.00 (24.76%) | Buy | 58.25 |
Show more |
No data within this time range.
Date | Type | Details |
---|---|---|
17 Dec 2024 | Announcement | Doximity Report Confirms That Telemedicine Serves Key Role in Modern Health Care |
07 Nov 2024 | Announcement | Doximity Announces Fiscal 2025 Second Quarter Financial Results |
31 Oct 2024 | Announcement | Doximity to Present at the Jefferies London Healthcare Conference |
17 Oct 2024 | Announcement | Doximity to Release Fiscal 2025 Second Quarter Results on November 7, 2024 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
Realized Profit | - |
Unrealized Profit | - |
Dividend Received 2025 | - |
Total Profit | - |
Avg. Return | - |
Quantity (Buy) | - |
Avg. Price (Buy) | - |
Quantity (Sold) | - |
Avg. Price (Sold) | - |